What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

EasyM

Call Directions Website Contact the business

EasyM is a blood-based test for Multiple Myeloma minimal residual disease (MRD). Available in US and Canada, not FDA approved.

10/10/2026

It was a pleasure to attend the Myeloma Canada | Myélome Canada MRD Harmonization Workshop and connect with experts working to advance MRD testing in multiple myeloma for Canadians.

It was also a great opportunity to share that EasyM is available across Canada and to introduce more of the community to our blood-based solution.

Thank you to Myeloma Canada and everyone involved for the insightful discussions and collaboration. We’re proud to be part of this important conversation!

10/01/2026

A big thank you to the Hematology team at Grand River Hospital for welcoming us for a Lunch & Learn!

We enjoyed connecting with your team, sharing insights, and discussing the evolving field of blood-based MRD testing. 🩸

It was a pleasure to introduce EasyM and share more about our blood-based MRD technology for multiple myeloma and the exciting advances in this space.

💭 Interested in learning more about EasyM? Send us a DM - we’d love to connect and arrange a Lunch & Learn with your team!

09/28/2026

What an incredible ⭐️

An amazing meeting filled with groundbreaking data, excellent presentations and posters, and so many inspiring connections across the myeloma community.

One theme that stood out was the rapidly evolving role of blood-based techniques for sensitive, longitudinal disease tracking.🩸

The new IMS/IMWG consensus definition of cure, incorporating sustained MRD negativity over 5 years off treatment, further highlights how central sensitive MRD assessment is becoming in the future of myeloma care.

Thank you to everyone who we connected with it was such a pleasure 🤝

09/21/2026

✈️ The EasyM Team is wheels up!

We’re heading to meeting and are excited to share our latest work with the myeloma community.

📌 Poster # PA-373

“Prospective Study of Peripheral Residual Disease (PRD) Monitoring by Clonotypic Mass Spectrometry (EasyM) in Patients with Newly Diagnosed Multiple Myeloma”

Looking forward to sharing our findings, connecting with colleagues, and exchanging ideas on the future of multiple myeloma research.

Visit our booth or DM us to set up a time to chat - see you in Glasgow! 🤝

09/18/2026

🩸💪 ONE WEEK TO DOUBLE YOUR IMPACT!

On September 25 at 2 PM ET, every donation to the EasyM team will be matched by us, meaning your support can go twice as far.

👉 Support the EasyM team: https://lnkd.in/gQMrqUM6

Every donation supports Myeloma Canada - National Page and helps bring us closer to better treatments, better outcomes, and a future where multiple myeloma is no longer life-limiting.

One week. Double the impact. Together, let’s make a difference. ❤️

09/17/2026

The EasyM team is excited to be attending the International Myeloma Society (IMS) 2026 Annual Meeting in Glasgow next week! 🎉

We’re looking forward to connecting, learning the latest advances in myeloma research, and having great conversations with the community.

Will you be at IMS 2026? DM us to set up a time to meet, we’d be happy to chat! 🤝

See you in Glasgow!

09/09/2026

🩸💪 We’re 50% of the way to our goal!

DOUBLE YOUR IMPACT 🙌

At 2 PM ET on September 25 all donations will be matched by us!

👉 Support the EasyM team: https://support.myeloma.ca/site/TR/MultipleMyelomaMarch/General?pg=team&team_id=8535&fr_id=2014

Every donation supports Myeloma Canada - National Page and brings us closer to better treatments, better outcomes, and a future where multiple myeloma is no longer life-limiting.

Together, let's make a difference ❤️

$Early treatment failure after CAR-T: can we identify patients at risk?A new study of patients with relapsed/refractory m...$

09/04/2026

Early treatment failure after CAR-T: can we identify patients at risk?

A new study of patients with relapsed/refractory multiple myeloma treated with ciltacabtagene autoleucel (cilta-cel) found that:

• Prior BCMA-directed therapy, extramedullary disease, and CAR-HEMATOTOX ≥2 were independent predictors of early progression or death.
• MRD positivity at 3 months was associated with a significantly higher risk of early treatment failure.
• Less than complete response on FDG PET/CT at 3 months was also strongly associated with early treatment failure.

These findings highlight the potential value of early and sensitive disease monitoring after CAR-T, particularly for identifying patients who may need closer follow-up or new therapeutic strategies.

📄 Read the study: https://onlinelibrary.wiley.com/doi/10.1002/ajh.70425

09/01/2026

🩸 September is Blood Cancer Awareness Month 🩸

Did you know Multiple Myeloma is the 2nd most common blood cancer in the world?

This month and always, we pledge to:

- Stand with patients and families
- Raise awareness of Multiple Myeloma
- Drive research forward

Every share, every conversation, and every act of support brings us one step closer to a future with better options for all.

08/28/2026

Step Up for Canadians Living with Multiple Myeloma 🩸💪

On September 27, the EasyM team will join the Kitchener-Waterloo Multiple Myeloma March in support of
Myeloma Canada - National Page

Your donation helps:
- Advance research toward better treatments and outcomes
- Strengthen patient advocacy and access to new therapies

Double your impact ‼️

Donate by September 25 and your contribution could go twice as far.
At 2 PM ET on September 25, 2026, we will match the total amount raised by our team at that time, effectively doubling every donation made.

Every donation brings us closer to better treatments, better outcomes, and a future where multiple myeloma is no longer life-limiting.

Support our team and help us reach our goal:
https://support.myeloma.ca/site/TR/MultipleMyelomaMarch/General?pg=team&team_id=8535&fr_id=2014

Together, every step makes a difference.

Address

EasyM C/o Rapid Novor Inc. , Unit 450, 137 Glasgow Street
Kitchener, ON
N2G4X8

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+18558999990

Website

http://www.easym.com/

Alerts

Be the first to know and let us send you an email when EasyM posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to EasyM:

Want your business to be the top-listed health & beauty business in Kitchener?